Philmore Crichlow

Philmore Crichlow serves as a key procurement professional within the Naval Medical Logistics Command, supporting the readiness of U.S. Navy and Marine Corps medical forces through the acquisition of critical diagnostic, laboratory, and life-sustaining medical systems. Responsible for managing complex contracting actions aligned with the command’s mission to sustain global medical logistics, Crichlow specializes in securing advanced in-vitro diagnostic substances, analytical laboratory instruments, and point-of-care diagnostic technologies essential for combat casualty care and preventive medicine operations. His acquisitions directly enable clinical readiness across deployed and shore-based medical facilities, ensuring compliance with DoD standards for medical equipment reliability and supply chain resilience. Crichlow maintains collaborative relationships with a diverse range of vendors, including manufacturers of diagnostic reagents, analytical instrumentation, and specialized laboratory services. While no single contractor dominates his portfolio, his contracting patterns reflect a balanced engagement with both large-scale medical technology suppliers and agile small businesses capable of rapid response and technical innovation. His approach emphasizes performance-based contracting, technical validation, and lifecycle support, ensuring procured systems meet stringent military medical requirements under austere operational conditions. A strong advocate for small business participation, Crichlow consistently prioritizes Total Small Business Set-Asides under FAR 19.5, with nearly 38% of his acquisitions reserved for small businesses. This reflects a deliberate strategy to foster innovation and diversify the supplier base, particularly among firms with expertise in diagnostic manufacturing and clinical testing services. His contracting patterns show minimal use of other socioeconomic set-asides, indicating a focused reliance on the general small business category to meet mission-critical needs. His primary procurement focus lies in NAICS 325413 (in-vitro diagnostic substance manufacturing) and 334516 (analytical laboratory instrument manufacturing), with significant activity in testing laboratory services and water supply systems supporting medical facility operations. Crichlow’s technical expertise spans clinical diagnostics, laboratory automation, and medical infrastructure, making him a vital link between operational medical requirements and the industrial base delivering next-generation diagnostic capabilities.